Dexpanthenol

CHEMBL1200979 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
205.2 g/mol
LogP
-0.9
Phase
4

The d-isomer of pantothenol (provitamin B5) that is converted to pantothenic acid in the body, used topically as a moisturizer and wound-healing agent, and parenterally to stimulate bowel motility after surgery. It supports synthesis of coenzyme A and promotes skin barrier function.

Masse moléculaire

205,2500 g/mol

LogP

-0,90

TPSA

89,80 Ų

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Mécanisme d'action

Forms an occlusive barrier on the skin surface, reducing transepidermal water loss and protecting the underlying tissue from external irritants.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mécanisme

Forms an occlusive barrier on the skin surface, reducing transepidermal water loss and protecting the underlying tissue from external irritants.

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(C)(CO)[C@@H](O)C(=O)NCCCO

InChI

InChI=1S/C9H19NO4/c1-9(2,6-12)7(13)8(14)10-4-3-5-11/h7,11-13H,3-6H2,1-2H3,(H,10,14)/t7-/m0/s1

Molecular Formula

C9H19NO4

HBD / HBA

4 / 4

Liaisons Rotatives

6

Atomes Lourds

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

The d-isomer of pantothenol (provitamin B5) that is converted to pantothenic acid in the body, used topically as a moisturizer and wound-healing agent, and parenterally to stimulate bowel motility after surgery. It supports synthesis of coenzyme A and promotes skin barrier function.

Forms an occlusive barrier on the skin surface, reducing transepidermal water loss and protecting the underlying tissue from external irritants.

Yes, Dexpanthenol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200979. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 131204. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.